These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 10882

  • 1. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD.
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [Abstract] [Full Text] [Related]

  • 2. Propranolol in the treatment of angina: a review.
    Prichard BN.
    Postgrad Med J; 1976; 52 Suppl 4():35-41. PubMed ID: 787954
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL.
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [Abstract] [Full Text] [Related]

  • 5. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL, Manyari DE, Kostuk WJ.
    Can Med Assoc J; 1984 Jun 01; 130(11):1449-55. PubMed ID: 6145515
    [Abstract] [Full Text] [Related]

  • 6. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN.
    Drugs; 1974 Jun 01; 7(1):55-84. PubMed ID: 4151695
    [No Abstract] [Full Text] [Related]

  • 7. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U.
    Herz; 1982 Jun 01; 7(3):179-87. PubMed ID: 6124493
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB, DeFelice EA, Frishman W, Hosler M, Krieger SK, Aglitz N, Kuo PT.
    Angiology; 1981 Nov 01; 32(11):780-7. PubMed ID: 6119937
    [Abstract] [Full Text] [Related]

  • 9. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B, Nelson GI, Verma SP, Ahuja RC, Okoli RC, Hussain M, Taylor SH.
    Herz; 1984 Feb 01; 9(1):57-64. PubMed ID: 6368345
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U, Davidson C, Singleton W, Taylor SH.
    N Engl J Med; 1979 Apr 05; 300(14):750-5. PubMed ID: 581782
    [Abstract] [Full Text] [Related]

  • 11. Differences in betablocking drugs in cardiovascular therapy.
    Iisalo E, Heikkilä J.
    Ann Clin Res; 1988 Apr 05; 20(5):324-33. PubMed ID: 2905877
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of beta adrenergic blocking drugs.
    Sowton E, Das Gupta DS, Baker I.
    Thorax; 1975 Feb 05; 30(1):9-18. PubMed ID: 235803
    [Abstract] [Full Text] [Related]

  • 13. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF, Grytter C, Thomsen S, Sigurd B.
    Clin Exp Pharmacol Physiol Suppl; 1982 Feb 05; 6():31-41. PubMed ID: 6126287
    [Abstract] [Full Text] [Related]

  • 14. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB, Frishman W, Hosler MH, Thorsen NL, Gonasun L, Weinstein J.
    Am Heart J; 1982 Aug 05; 104(2 Pt 2):496-504. PubMed ID: 7102536
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of pindolol.
    Aellig WH.
    Am Heart J; 1982 Aug 05; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [Abstract] [Full Text] [Related]

  • 16. The properties of beta-adrenoceptor antagonists.
    Shanks RG.
    Postgrad Med J; 1976 Aug 05; 52 Suppl 4():14-20. PubMed ID: 9628
    [Abstract] [Full Text] [Related]

  • 17. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.
    Frishman W, Kostis J, Strom J, Hossler M, Elkayam U, Goldner S, Silverman R, Davis R, Weinstein J, Sonnenblick E.
    Am Heart J; 1979 Oct 05; 98(4):526-35. PubMed ID: 39447
    [No Abstract] [Full Text] [Related]

  • 18. [Beta blockers in migraine prophylaxis].
    Shimizu T.
    Brain Nerve; 2009 Oct 05; 61(10):1125-30. PubMed ID: 19882938
    [Abstract] [Full Text] [Related]

  • 19. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE, Kostuk WJ, Carruthers SG, Johnston DJ, Purves P.
    Am J Cardiol; 1983 Feb 05; 51(3):427-33. PubMed ID: 6401908
    [Abstract] [Full Text] [Related]

  • 20. Haemodynamic effects of intravenous beta-blocking drugs in coronary heart disease.
    Taylor SH, Silke B, Nelson GI.
    J Pharmacol; 1983 Feb 05; 14 Suppl 2():157-67. PubMed ID: 6138465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.